4 12, 2017 G Aggarwal et. al, SOX2 Immunoexpression in High-Grade Gliomas: Potential Marker for Targeted Therapy Diatech Pharmacogenetics2018-01-30T10:38:34+01:00 Leggi di più
18 09, 2017 Elena Ongaro et al., 552PMutational status and metastatic patteRn in a cohort Of ADvanced colorectal cancer (aCRC) patients (pts): The ROAD study Diatech Pharmacogenetics2020-01-22T09:23:08+01:00 Leggi di più
18 07, 2017 Federico Pessina et al., Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution. Future Medicine Diatech Pharmacogenetics2017-08-03T11:05:28+02:00 Leggi di più
28 06, 2017 Pierina Navarria et al., Are three weeks hypofractionated radiation therapy (HFRT) comparable to six weeks for newly diagnosed glioblastoma patients? Results of a phase II study Diatech Pharmacogenetics2017-11-21T16:09:45+01:00 Leggi di più
1 03, 2017 Giulia Morosetti et al., Ellagic acid and Annona muricata in the chemoprevention of HPV-related pre-neoplastic lesions of the cervix. Diatech Pharmacogenetics2017-11-02T13:03:08+01:00 Leggi di più
23 01, 2017 Giulia Morosetti et al., Ellagic acid and Annona muricata in the chemoprevention of HPV-related pre-neoplastic lesions of the cervix. Oncology Letters Diatech Pharmacogenetics2017-08-25T09:47:32+02:00 Leggi di più
21 01, 2017 Egesta Lopci et al., Prognostic value of molecular and imaging biomarkers in patients with supratentorial glioma. European Journal of Nuclear Medicine and Molecular Imaging Diatech Pharmacogenetics2017-08-03T16:49:54+02:00 Leggi di più
1 01, 2017 Elisabetta Macerola et al., BRAFK601E Mutation in a Follicular Thyroid Adenoma: A Case Report. International Journal of Surgical Pathology Diatech Pharmacogenetics2017-08-03T16:59:54+02:00 Leggi di più
8 12, 2016 Beth O. Van Emburgh et al., Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer. Nature Communications Diatech Pharmacogenetics2017-08-03T17:32:43+02:00 Leggi di più
27 11, 2016 Adriana Romiti et al., The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer. Anti-Cancer Drugs Diatech Pharmacogenetics2017-08-07T10:02:57+02:00 Leggi di più
